debrisoquin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaw, GL | 1 |
| Falk, RT | 1 |
| Deslauriers, J | 1 |
| Nesbitt, JC | 1 |
| McKneally, MF | 1 |
| Frame, JN | 1 |
| Feld, R | 1 |
| Issaq, HJ | 1 |
| Ruckdeschel, JC | 1 |
| Hoover, RN | 1 |
| Roots, I | 1 |
| Drakoulis, N | 1 |
| Ploch, M | 1 |
| Heinemeyer, G | 1 |
| Loddenkemper, R | 1 |
| Minks, T | 1 |
| Nitz, M | 1 |
| Otte, F | 1 |
| Koch, M | 1 |
2 other studies available for debrisoquin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Lung tumor resection does not affect debrisoquine metabolism.
Topics: Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Debrisoquin; Female; Humans; Lung Neoplasms; M | 1994 |
Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Topics: ABO Blood-Group System; Acetylation; Acetyltransferases; Arylamine N-Acetyltransferase; Caffeine; Ca | 1988 |